Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label NEJM. Show all posts
Showing posts with label NEJM. Show all posts
Thursday, March 29, 2012

Letter: Bevacizumab in Ovarian Cancer — NEJM

›
Bevacizumab in Ovarian Cancer — NEJM Correspondence Bevacizumab in Ovarian Cancer N Engl J Med 2012; 366:1256-1258   March 29, 2012...
Monday, January 30, 2012

open access: Editorial - Ovarian cancer: breaking the silence : The Lancet Oncology (references Avastin studies and NEJM)

›
Ovarian cancer: breaking the silence The Lancet Oncology   "The heterogeneous nature of cancer makes it a very difficult dis...
Monday, January 16, 2012

open access: Combination Drugs — Hype, Harm, and Hope — NEJM

›
Sunday, January 15, 2012

New Articles -- EvidenceUpdates: A phase 3 trial of bevacizumab in ovarian cancer - abstract, reference + professional commentaries

›
also see linked reference: Perren TJ, Swart AM, Pfisterer J, et al. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011 ...
Friday, December 30, 2011

Obstetrics/Gynecology articles: The New England Journal of Medicine (2 articles)

›
SpecialtyObstetrics/Gynecology original article Bevacizumab in the Treatment of Ovarian Cancer December 29, 2011 | R.A. Burger ...

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer — NEJM

›
Blogger's Note: see also the section 'Media in This Article'
Tuesday, June 15, 2010

NEJM -- The Path to Personalized Medicine (U.S.)

›
"...In February, the NIH and the FDA announced a new collaboration on regulatory and translational science to accelerate the translat...
Tuesday, April 20, 2010

NEJM -- Gene Patenting -- Is the Pendulum Swinging Back?

›